News
04-30-2012, 08:00 AM
Bio-Reference Laboratories, Inc. announced today that it has completed an equity investment in InCellDx, Inc., a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant rejection.
More... (http://www.news-medical.net/news/20120430/BRLI-completes-equity-investment-in-InCellDx.aspx)
More... (http://www.news-medical.net/news/20120430/BRLI-completes-equity-investment-in-InCellDx.aspx)